PT Kalbe Farma Tbk. (IDX:KLBF)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
1,355.00
-55.00 (-3.90%)
Aug 22, 2025, 4:13 PM WIB
-3.90%
Market Cap61.51T
Revenue (ttm)33.38T
Net Income (ttm)3.41T
Shares Out45.39B
EPS (ttm)74.49
PE Ratio18.19
Forward PE17.97
Dividend36.00 (2.66%)
Ex-Dividend DateJun 4, 2025
Volume84,425,300
Average Volume44,108,405
Open1,395.00
Previous Close1,410.00
Day's Range1,335.00 - 1,410.00
52-Week Range985.00 - 1,795.00
Beta0.01
RSI38.56
Earnings DateAug 1, 2025

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic divisions. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company pr... [Read more]

Sector Healthcare
Founded 1966
Employees 12,903
Stock Exchange Indonesia Stock Exchange
Ticker Symbol KLBF
Full Company Profile

Financial Performance

In 2024, PT Kalbe Farma Tbk.'s revenue was 32.63 trillion, an increase of 7.16% compared to the previous year's 30.45 trillion. Earnings were 3.24 trillion, an increase of 17.13%.

Financial Statements

News

There is no news available yet.